Internal medicine

Suppressor

Cancer

Engineering

Oncology

Chemistry

Tamoxifen

Sensitivity (control systems)

Electronic engineering

Tumor progression

Breast cancer

Breast tumor

Cancer research

Medicine

Molecular Therapy

(Molecular Therapy 27, 1638–1652; September 2019) In the originally published article, in Figures S2E, S3D, and S6D, the transwell images were incorrectly used. The assembly of Figure S6E was wrong. The corrected images are shown below. The errors do not impact the findings or conclusions of the study. The authors apologize for this error.Figure S3. Hsa_circ_0025202 suppresses growth, metastasis and increases TAM sensitivity of HR-positive BC cells in vitroView Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure S6. Has_circ_0025202 sponges miR-182-5p to regulate the tumor progression and TAM sensitivity of BC cellsView Large Image Figure ViewerDownload Hi-res image Download (PPT) circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast CancerSang et al.Molecular TherapyMay 16, 2019In BriefThis report demonstrates a novel circular RNA, named hsa_circ_0025202, which is downregulated in tamoxifen-resistant breast cancer cells. hsa_circ_0025202 was identified as a tumor suppressor, and it could improve tamoxifen sensitivity through regulating the miR-182-5p/FOXO3a axis, suggesting it could be a potential therapeutic target and marker for patients with hormone receptor-positive breast cancer. Full-Text PDF Open Archive

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer